Literature DB >> 32550995

Construction and Evaluation of Molecular Models: Guide and Design of Novel SE Inhibitors.

Yunfei An1, Yue Dong1, Liu Min1, Liyu Zhao2, Dongmei Zhao2, Jun Han1, Bin Sun1.   

Abstract

Squalene epoxidase (SE) was considered an important antifungal target to block ergosterol synthesis. In this study, molecular models of CASE including the homology model and the SBP were constructed, respectively. Three representative SE inhibitors were selected and docked into the active site of CASE. Subsequently, the novel SE inhibitors were designed based on the analysis of the inhibitor binding mode and the distribution of pharmacophore features. These compounds were further synthesized and tested in vitro. They exhibited a certain degree of antifungal activity, especially compound 7a-2, which also has a significant inhibitory effect on resistant fungi. Further analysis found that compound 7a-2 could inhibit SE, which is similar to naftifine. The study proved the rationality of the molecular models; they can help us design and discover more potent antifungal SE inhibitors.
Copyright © 2020 American Chemical Society.

Entities:  

Year:  2020        PMID: 32550995      PMCID: PMC7294727          DOI: 10.1021/acsmedchemlett.0c00017

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  24 in total

Review 1.  Structure-based strategies for drug design and discovery.

Authors:  I D Kuntz
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

2.  Design, synthesis, and structure-activity relationship studies of novel thienopyrrolidone derivatives with strong antifungal activity against Aspergillus fumigates.

Authors:  Xufeng Cao; Yuanyuan Xu; Yongbing Cao; Ruilian Wang; Ran Zhou; Wenjing Chu; Yushe Yang
Journal:  Eur J Med Chem       Date:  2015-08-19       Impact factor: 6.514

3.  VERIFY3D: assessment of protein models with three-dimensional profiles.

Authors:  D Eisenberg; R Lüthy; J U Bowie
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

Review 4.  The biology and chemistry of antifungal agents: a review.

Authors:  Muthu K Kathiravan; Amol B Salake; Aparna S Chothe; Prashik B Dudhe; Rahul P Watode; Maheshwar S Mukta; Sandeep Gadhwe
Journal:  Bioorg Med Chem       Date:  2012-05-09       Impact factor: 3.641

5.  Design, synthesis, and structure-activity relationship studies of benzothiazole derivatives as antifungal agents.

Authors:  Shizhen Zhao; Liyu Zhao; Xiangqian Zhang; Chunchi Liu; Chenzhou Hao; Honglei Xie; Bin Sun; Dongmei Zhao; Maosheng Cheng
Journal:  Eur J Med Chem       Date:  2016-07-29       Impact factor: 6.514

6.  Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies.

Authors:  Dongmei Zhao; Shizhen Zhao; Liyu Zhao; Xiangqian Zhang; Peng Wei; Chunchi Liu; Chenzhou Hao; Bin Sun; Xin Su; Maosheng Cheng
Journal:  Bioorg Med Chem       Date:  2016-11-28       Impact factor: 3.641

Review 7.  Echinocandin antifungal drugs in fungal infections: a comparison.

Authors:  Sharon C-A Chen; Monica A Slavin; Tania C Sorrell
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

Review 8.  Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.

Authors:  Geehan Suleyman; George J Alangaden
Journal:  Infect Dis Clin North Am       Date:  2016-12       Impact factor: 5.982

9.  In vitro polymyxin activity against clinical multidrug-resistant fungi.

Authors:  Hanane Yousfi; Stéphane Ranque; Jean-Marc Rolain; Fadi Bittar
Journal:  Antimicrob Resist Infect Control       Date:  2019-04-24       Impact factor: 4.887

10.  4-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency.

Authors:  Claudia M Calvet; Debora F Vieira; Jun Yong Choi; Danielle Kellar; Michael D Cameron; Jair Lage Siqueira-Neto; Jiri Gut; Jonathan B Johnston; Li Lin; Susan Khan; James H McKerrow; William R Roush; Larissa M Podust
Journal:  J Med Chem       Date:  2014-08-19       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.